RxSight, Inc. is a US-based healthcare company focused on enhancing post-cataract surgery patient vision. Specializing in customized intraocular lens technology, RxSight aims to optimize visual acuity for patients. With an ESG score of 21.6, the company is considered a medium risk investment. Operating in the research, development, manufacture, and sale of light adjustable lenses, RxSight is dedicated to improving patient outcomes in the healthcare industry.